Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0
Sign in

Lorlatinib — mesenchymal druggability

MeasuredDerived

Inhibition of Lorlatinib across the 47 mesenchymal-specific kinases of Table S9 (1 µM single dose). Weighted inhibition 9.5% · mean inhibition 11.5% · 1/47 kinases inhibited to ≤ 35% residual activity.

Strongest inhibition shown left. Inhibition % = 100 − residual activity %.

Per-kinase profile

Kinase (RBC label)HGNCResidual %Inhibition %Mes/epi fold-changeStatus
DCAMKL2DCLK230.369.71.52Upregulated
CAMK2DCAMK2D52.747.31.19Upregulated
EGFREGFR61.338.71.50Upregulated
LIMK1LIMK162.837.21.10Upregulated
EPHA2EPHA269.230.81.22Upregulated
PEAK1PEAK169.730.31.59Upregulated
ARK5_NUAK1NUAK170.529.51.97Upregulated
MEKK3MAP3K373.426.61.03Upregulated
ALK2_ACVR1ACVR176.523.51.66Upregulated
TGFBR2TGFBR279.520.52.39Upregulated
PKCMU_PRKD1PRKD180.519.52.02Upregulated
EPHA4EPHA481.218.81.10Upregulated
ALK5_TGFBR1TGFBR185.114.91.12Upregulated
PKCNU_PRKD3PRKD387.112.91.04Upregulated
EPHA5EPHA588.111.91.50Upregulated
LATS2LATS288.611.41.37Upregulated
PDGFRAPDGFRA89.910.12.74Upregulated
FYNFYN91.18.91.85Upregulated
BMPR2BMPR292.27.81.10Upregulated
FGFR1FGFR193.16.92.73Upregulated
NEK7NEK793.26.81.54Upregulated
TIE2_TEKTEK93.46.61.16Upregulated
DRAK1_STK17ASTK17A94.06.01.98Upregulated
HIPK2HIPK294.35.71.12Upregulated
MLCK_MYLKMYLK94.65.44.25Upregulated
DYRK3DYRK395.24.81.57Upregulated
EPHB2EPHB295.44.61.15Upregulated
HGK_MAP4K4MAP4K495.84.21.66Upregulated
CAMK4CAMK496.04.01.06Upregulated
CAMK1ACAMK196.53.51.86Upregulated
ZIPK_DAPK3DAPK396.53.51.16Upregulated
ABL2_ARGABL296.93.11.66Upregulated
JAK1JAK197.62.41.17Upregulated
PLK2PLK297.82.22.42Upregulated
NEK6NEK698.31.71.67Upregulated
AKT3AKT398.91.12.59Upregulated
PDGFRBPDGFRB100.00.03.93Upregulated
RSK3RPS6KA2100.00.01.66Upregulated
SGK1SGK1100.00.02.88Upregulated
PKCAPRKCA100.00.02.09Upregulated
AXLAXL100.00.05.65Upregulated
DDR2DDR2100.00.03.68Upregulated
CDK15_CYCLIN_A2CDK15100.00.02.05Upregulated
DLK_MAP3K12MAP3K12100.00.01.29Upregulated
C_METMET100.00.01.20Upregulated
PKACBPRKACB100.00.01.25Upregulated
STK32B_YANK2STK32B100.00.01.72Upregulated

← All inhibitors